Elsa Bernard

机构：Inserm, Université Paris-Saclay, Institut Gustave Roussy · ORCID：0000-0002-2057-7187

发表论文 364 篇 · 总被引 4353 次 · h-index 23

代表论文

• Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 study (2026 · Cancer Cell · 被引 8)
• The role of the adenosinergic pathway in resistance to hypomethylating agents in patients with high‐risk myelodysplastic syndromes (2026 · British Journal of Haematology)
• Real-world investigation of germline predisposition to myelodysplastic syndromes (2026 · Blood Advances)
• Erratum: Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model (2026 · Journal of Clinical Oncology)
• Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model (2026 · Journal of Clinical Oncology)
• Supplemental figure S5 from Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States (2026)